» Articles » PMID: 38390617

Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors

Overview
Specialty Psychiatry
Date 2024 Feb 23
PMID 38390617
Authors
Affiliations
Soon will be listed here.
Abstract

Substance use disorder (SUD) is a prevalent disease that has caused hundreds of thousands of deaths and affected the lives of even more. Despite its global impact, there is still no known cure for SUD, or the psychological symptoms associated with drug use. Many of the behavioral consequences of drug use prevent people from breaking the cycle of addiction or cause them to relapse back into the cycle due to the physical and psychological consequences of withdrawal. Current research is aimed at understanding the cause of these drug related behaviors and therapeutically targeting them as a mechanism to break the addiction cycle. Research on opioids suggests that the changes in the microbiome during drug use modulated drug related behaviors and preventing these microbial changes could attenuate behavioral symptoms. This review aims to highlight the relationship between the changes in the microbiome and behavior during opioid treatment, as well as highlight the additional research needed to understand the mechanism in which the microbiome modulates behavior to determine the best therapeutic course of action.

Citing Articles

Trihexyphenidyl Alters Its Host's Metabolism, Neurobehavioral Patterns, and Gut Microbiome Feedback Loop-The Modulating Role of .

Baslam A, Azraida H, Aboufatima R, Ait-El-Mokhtar M, Dilagui I, Boussaa S Antioxidants (Basel). 2024; 13(1).

PMID: 38275646 PMC: 10812446. DOI: 10.3390/antiox13010026.


Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs.

Trunfio M, Chaillon A, Beliakova-Bethell N, Deiss R, Letendre S, Riggs P Viruses. 2023; 15(8).

PMID: 37632053 PMC: 10458944. DOI: 10.3390/v15081712.


Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications.

Tsigalou C, Paraschaki A, Bragazzi N, Aftzoglou K, Bezirtzoglou E, Tsakris Z Front Cell Infect Microbiol. 2023; 13:1191126.

PMID: 37333847 PMC: 10272562. DOI: 10.3389/fcimb.2023.1191126.

References
1.
Sullivan R, Duchesne A, Hussain D, Waldron J, Laplante F . Effects of unilateral amygdala dopamine depletion on behaviour in the elevated plus maze: role of sex, hemisphere and retesting. Behav Brain Res. 2009; 205(1):115-22. DOI: 10.1016/j.bbr.2009.07.023. View

2.
Lach G, Schellekens H, Dinan T, Cryan J . Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. Neurotherapeutics. 2017; 15(1):36-59. PMC: 5794698. DOI: 10.1007/s13311-017-0585-0. View

3.
Vuong H, Yano J, Fung T, Hsiao E . The Microbiome and Host Behavior. Annu Rev Neurosci. 2017; 40:21-49. PMC: 6661159. DOI: 10.1146/annurev-neuro-072116-031347. View

4.
Kelly J, Kennedy P, Cryan J, Dinan T, Clarke G, Hyland N . Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015; 9:392. PMC: 4604320. DOI: 10.3389/fncel.2015.00392. View

5.
Lyte M, Varcoe J, Bailey M . Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol Behav. 1998; 65(1):63-8. DOI: 10.1016/s0031-9384(98)00145-0. View